Almotrefi A A, Baker J B
J Pharm Pharmacol. 1980 Nov;32(11):746-50. doi: 10.1111/j.2042-7158.1980.tb13059.x.
The effectiveness of three new antiarrhythmic drugs, aprindine, mexiletine and tocainide in elevating ventricular fibrillation threshold measured in the Langendorff-perfused rabbit heart and in protecting against ouabain-induced arrhythmias in the Langendorff-perfused guinea-pig heart has been compared with that of lignocaine. All these drugs have produced a significant rise in the threshold but quantitatively mexiletine was about equal to, tocainide five times less and aprindine thirty-eight times more potent than lignocaine in this effect. Aprindine differed from the other three drugs in that it had a slow onset of action and its effect was not entirely removed upon reperfusion with the drug-free solution. Only aprindine and mexiletine provided complete protection against ouabain-induced ventricular fibrillation while 3 of 6 and 4 of 6 hearts fibrillated in the presence of lignocaine or tocainide respectively.
已将三种新型抗心律失常药物——安搏律定、美西律和妥卡尼,在Langendorff灌注兔心脏中提高室颤阈值以及在Langendorff灌注豚鼠心脏中预防哇巴因诱发心律失常的有效性,与利多卡因进行了比较。所有这些药物均使阈值显著升高,但在这一作用上,从定量角度而言,美西律约与利多卡因相当,妥卡尼的效力仅为利多卡因的五分之一,而安搏律定的效力则是利多卡因的三十八倍。安搏律定与其他三种药物的不同之处在于,其起效缓慢,且在用无药溶液再灌注后,其作用并未完全消除。只有安搏律定和美西律能完全预防哇巴因诱发的室颤,而在利多卡因或妥卡尼存在的情况下,分别有6只心脏中的3只和6只心脏中的4只发生了颤动。